Cavim 2.5Gm Injection, 2.25Gm

Cavim 2.5 gm Injection (Ceftazidime and Avibactam)
Cavim 2.25 gm Injection is a combination antibiotic medication containing Ceftazidime (2 gm) and Avibactam (0.25 gm). It is primarily used to treat serious bacterial infections caused by susceptible organisms, particularly those resistant to other antibiotics.
Composition
Ceftazidime: A third-generation cephalosporin antibiotic that inhibits bacterial cell wall synthesis, leading to bacterial cell death.
Avibactam: A beta-lactamase inhibitor that protects ceftazidime from degradation by certain bacterial enzymes, thereby enhancing its effectiveness.
Indications
Cavim 2.25 gm Injection is used to treat various serious bacterial infections, including:
Complicated Urinary Tract Infections (cUTIs): Including pyelonephritis.
Complicated Intra-Abdominal Infections (cIAIs): Often in combination with other antibiotics like metronidazole.
Hospital-Acquired Pneumonia (HAP) and Ventilator-Associated Pneumonia (VAP): In adults with limited treatment options.
Bloodstream Infections (Bacteremia): Caused by multidrug-resistant organisms.